Navigation Links
Routine Checkups Don't Cut Cancer, Heart Deaths: Study
Date:11/21/2012

By Alan Mozes
HealthDay Reporter

TUESDAY, Nov. 20 (HealthDay News) -- Routine checkups don't help reduce a patient's risk of dying from either heart disease or cancer, new Danish research suggests.

The finding applies to doctor visits among the general population, in which seemingly healthy patients, without any specific disease risk, come in on a regular basis for an array of standardized screenings and lifestyle counseling.

The goal of such checkups is to catch early signs of disease and thereby reduce the risk for early death.

But the fresh review of 14 previous studies involving nearly 183,000 patients uncovered no evidence that such checkups do anything of the sort. On the contrary, the research team found that routine checkups of healthy people may actually promote the use of potentially harmful invasive testing while at the same time leading to overdiagnosis and unnecessary treatment.

"We could not find evidence of benefit from adding systematic, regular health checks to ordinary preventive health care practice, despite having data from many trials of high quality that included almost 200,000 people," said study lead author Lasse Krogsboll, a doctoral candidate in the Nordic Cochrane Centre, in Copenhagen.

Krogsboll added, however, that part of the lack of notable checkup benefit might be due to prevention interventions having already been carried out by primary care physicians outside the checkup context among at-risk patients who they had already been seeing for other reasons throughout the year.

"[So] our results should not be interpreted as evidence against preventive actions to improve health in general," he said, "or evidence against clinicians trying to identify health problems early and treat risk factors in high-risk groups."

Krogsboll pointed out that "we are not saying that early treatment of manifest disease or treatment of risk factors identified as a part of good doctoring is not a good idea. For example, treatment of moderately or severely elevated blood pressure is well documented to be beneficial."

But, he added, "we cannot take it for granted that more diagnoses and more treatment is always better. Our results do not tell us what the optimal prevention strategy is, but they certainly do not support the idea of regular, systematic health checkups in addition to normal clinical practice."

Krogsboll and colleagues reported their findings in the Nov. 20 edition of the BMJ.

The studies selected for review dated as far back as 1947 and as recently as 2010. All of the participants were at least 18 years old, but no study was included in the review if it focused exclusively on seniors aged 65 and up.

All checkups had taken place in either a primary care or community care setting; none had occurred in a hospital clinic context.

Most studies included in the current review had been conducted in the United Kingdom and continental Europe, while some had taken place in the United States. Follow-up on patient deaths ranged from as low as four years to as much as 22 years after studies began.

The results: Checkups did lead to an uptick in overall diagnoses, as well as a specific increase in treatment for high blood pressure. However, such routine visits were not linked to any reduction in overall mortality or the risk of dying from cardiovascular illness or cancer.

The research team suggested another problem: Patients who decide on their own to go in for a routine physical may not actually be the sort -- such as those who haven't seen a doctor in a while -- who would most benefit from a checkup.

But just how broadly should the findings be interpreted?

"I do think that the results are applicable to America," Krogsboll said, pointing out that one study, in particular, had been conducted among Kaiser Permanente health plan members. However, he acknowledged that what exactly constitutes "optimal" preventive care is a matter of ongoing debate. He noted that the kind of care provided in some of the older European-based studies may not closely stack up against the current checkup protocols commonly practiced in the United States today.

In an accompanying editorial, Dr. Domhnall MacAuley, the London-based clinical primary care editor for BMJ, alluded to some unintended consequences that can stem from ineffective checkups.

"The potential downsides," MacAuley said, "are that those who come [in for a checkup] tend to be the 'worried well,' who may bear a high risk for being diagnosed with false positives or negatives. Indeed, [the study authors] suggested that there was overdiagnosis -- that routine checks tend to pick up conditions that were treated with no obvious benefit in terms of [illness] or mortality."

In his published commentary, MacAuley concluded that "policy should be based on evidence of well-being, rather than on well-meant good intentions" and rejects the notion that checkups for a healthy public are a good idea simply because "they seem a socially responsible approach to caring for patients."

That said, he suggests that "targeted" checkups may be the alternate way to go, by focusing on those patients who have already been identified as having risk factors or conditions that could benefit from routine monitoring.

More information

For more on recommended cancer screenings, visit the American Cancer Society. For more on cardiovascular disease prevention, visit the American Heart Association.

SOURCES: Lasse T. Krogsboll, Ph.D. candidate, Nordic Cochrane Centre, Righospitalet, Copenhagen; Domhnall MacAuley, M.D., clinical primary care editor, BMJ Editorial, London; Nov. 20, 2012, BMJ, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Routine blood test predicts prognosis in aggressive skin cancer
2. Routine electrocardiograms predict health risks for patients with atrial fibrillation
3. Routine Screening Wont Cut Rates of Domestic Violence, Study Suggests
4. Not Enough Data to Advise Routine Hearing Screens for Older People: Experts
5. Routine care for Crohns disease in children should include measurement of bone age
6. U.S. Advisers Say No to Routine PSA Tests for Prostate Cancer
7. Doctors Urge Routine Skin Screenings
8. Routine Kidney Disease Screening Not Worthwhile, Experts Say
9. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
10. IADR/AADR published study estimates high prevalence of periodontis in US adults
11. Statins May Cut Risk of Death From Cancer, Study Suggests
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Routine Checkups Don't Cut Cancer, Heart Deaths: Study
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... York, NY (PRWEB) , ... April 28, 2017 ... ... Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/18/2017)... SAN DIEGO and BLOOMINGTON, ... Pharmaceuticals, Inc. (NASDAQ: IMMY ) ("Imprimis"), ... d/b/a Precision Lens ("Precision Lens"), today announced the ... Under the agreement, Precision Lens will deploy a ... into select geographies in the U.S., primarily focused ...
Breaking Medicine Technology: